Patrys Ltd. | Balance Sheet

Fiscal year is July-June. All values AUD Thousands.
2014
2015
2016
2017
2018
Cash & Short Term Investments
8,673.60
4,655.60
3,215.00
1,911.00
6,605.50
Total Accounts Receivable
74.20
13.30
259.30
500.70
643.70
Other Current Assets
79.20
24.80
69.80
78.90
99.70
Total Current Assets
8,827.00
4,693.80
3,544.10
2,490.50
7,348.90
Net Property, Plant & Equipment
251.10
78.80
5.90
4.30
5.60
Intangible Assets
5,735.60
-
708.80
663.80
618.80
Total Assets
14,813.70
4,772.60
4,258.70
3,158.60
7,973.20
Accounts Payable
1,543.30
157.10
35.50
65.30
220.40
Other Current Liabilities
792.90
589.30
559.60
414.70
440.20
Total Current Liabilities
2,336.10
746.30
595.00
480.00
660.60
Provision for Risks & Charges
43.30
56.00
25.20
15.50
21.20
Total Liabilities
2,379.40
802.30
620.30
495.50
681.80
Common Equity (Total)
12,434.30
3,970.30
3,638.50
2,663.10
7,291.50
Total Shareholders' Equity
12,434.30
3,970.30
3,638.50
2,663.10
7,291.50
Total Equity
12,434.30
3,970.30
3,638.50
2,663.10
7,291.50
Liabilities & Shareholders' Equity
14,813.70
4,772.60
4,258.70
3,158.60
7,973.20

About Patrys

View Profile
Address
Level 4
South Melbourne Victoria (VIC) 3204
Australia
Employees -
Website http://www.patrys.com
Updated 07/08/2019
Patrys Ltd. engages in the commercialisation of the group's proprietary technologies to develop natural human antibody-based therapeutic products for the treatment of cancer and the pursuit of non-dilutive funding sources. It develops natural human antibody-based therapeutic products for the treatment of cancer. The company was founded by Daniel Devine on December 8, 2006 and is headquartered in South Melbourne, Australia.